Alkami Technology, Inc. recently reported second-quarter 2026 results, with revenue rising to US$129.84 million and net loss narrowing to US$8.9 million, while also issuing higher full-year revenue guidance and expanding its Plaid integration to offer cleaner, broader account connectivity for financial institutions on its digital banking platform.
A distinctive angle is how the embedded Plaid integration aims to simplify vendor management and data aggregation for Alkami’s bank and credit...
Crown Holdings, Inc. has already reported second-quarter 2026 results, with sales of US$3,668 million and net income of US$245 million, and its Board subsequently declared a US$0.35 per-share cash dividend payable on August 20, 2026, to shareholders of record as of August 6, 2026.
The company also completed a sizeable share repurchase program totaling 12,446,379 shares for about US$1.21 billion, which, alongside higher earnings per share, highlights a combination of returning cash to...
Five9 stock has staged a sharp rebound in the short term, yet the longer history is far harsher, which leaves the current valuation looking more like a reset than a clear bargain.
Over the past 5 years, Five9 has delivered a share price decline of about 87%, which means long term holders have seen a very large erosion of capital that any new thesis now has to justify.
Future revenue growth and progress toward stronger cash generation can support today’s price, while any sustained pressure on...
Verisk Analytics stock is coming off a year in which the share price fell 21.9%. The current valuation picture is mixed, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to about 17.1% upside, while traditional market multiples suggest the stock screens as expensive and the broader value checks are weak.
Over the past 12 months, Verisk Analytics has declined 21.9%, which means recent returns have been difficult for shareholders despite a stronger short term bounce.
The...
Leidos Holdings stock has fallen 37.7% year to date, yet its valuation checks and recent contract and product news are pointing investors back to the numbers on what they are paying for the business today.
Year to date the share price is down 37.7%, which puts the recent rebound over the past month into context as a move happening after a sizeable pullback.
New AI focused cybersecurity tools and recent defense contract wins can support sentiment on future revenue, while execution risk in...
On July 22, 2026, Casey's General Stores filed its definitive proxy statement urging shareholders to vote against a proposal to let investors owning at least 15% of outstanding shares call special shareholder meetings at the September 2, 2026 annual meeting.
At the same time, analysts are watching for the company’s upcoming fiscal 2027 first-quarter earnings, where expectations of double-digit profit growth highlight the tension between governance debates and operational execution.
We’ll now...
After a sharp 37.8% gain over the past month, WEX now sits near US$188, and the key issue for investors is that this strong share price move sits alongside valuation checks that lean more on the expensive side than on clear value.
The 37.8% move over the past month puts recent momentum front and center, which can leave less room for error if expectations do not hold up.
Growth in WEX's B2B payments and fleet fraud prevention offerings can support higher earnings expectations. However, any...
Pinnacle Financial Partners (PNFP) is back in focus after reporting second quarter 2026 net income of US$328 million, compared to US$159 million a year earlier, alongside updated common and preferred dividend declarations.
See our latest analysis for Pinnacle Financial Partners.
The recent earnings and dividend updates have arrived against a backdrop of steady gains for Pinnacle Financial Partners, with the share price at US$104.74, a 7 day share price return of 7.58% and a 1 year total...
Teladoc Health stock is coming off a very weak 5 year run, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both point to the shares screening as undervalued relative to those fundamentals.
Teladoc Health has seen its share price decline 93.9% over the past 5 years, which puts long term returns sharply at odds with the current view that the stock may now be priced below its underlying value.
The launch plans for the Teladoc One...
The market finally cut Unum Group some slack today. After drifting lower over the past month, the stock is up about 2% in live trading as investors digest a Q2 report that leans firmly on earnings power rather than headline revenue.
The core message is simple. Adjusted operating earnings per share of US$2.16 and a consolidated adjusted operating return on equity near 15.9% give bulls fresh ammunition, even as recent net profit margins over the last year sit well below the prior year. The...
Arm Holdings stock has surged 96.0% year to date, yet its low value score suggests the current price does not screen as a clear bargain on the broader checks.
Year to date, Arm Holdings has gained 96.0%, which sets a high bar for any further upside to be justified by fundamentals.
Strong positioning in AI servers and royalty growth can support higher earnings expectations, while recent share price volatility and concerns around smartphone demand may limit how much investors are willing to...
Nabors Industries stock is edging higher today, up about 2% in active trading, even though the fresh quarter again showed a loss at the earnings per share line. The market is reacting less to that headline loss and more to what sat behind it. Adjusted earnings before interest, tax, depreciation and amortization came in at roughly US$222 million with margins above 27%, ahead of management’s own targets. For a stock that has fallen over the past quarter, investors are now weighing that stronger...
Artificial intelligence stocks sit at the crossroads of several forces that investors are watching in 2026. Global growth signals are mixed, central banks continue to weigh inflation data, and energy costs remain a key swing factor. At the same time, demand for AI related chips, software, cloud and large language models links into real investment and trade flows across the US, Europe and Asia. This article uses an AI Stocks screener focused on companies directly involved in the ChatGPT and...
CubeSmart (CUBE) has reaffirmed its income return profile, with the Board of Trustees declaring a quarterly dividend of $0.53 per common share for the period ending September 30, 2026.
See our latest analysis for CubeSmart.
The reaffirmed dividend sits alongside a steady pick up in CubeSmart's share price momentum, with a 7 day share price return of 3.19% and a year to date share price return of 19.86%, while the 1 year total shareholder return is 9.09%.
If CubeSmart's steady income and price...
Big tech’s heavy spending on artificial intelligence is suddenly under the microscope after Meta shares dropped 11% on plans to lift annual spending to as much as US$145b, even as quarterly profit fell 14% to US$6b and free cash flow slid to a five year low of US$784 million. With Google also facing questions around the pay off from high AI budgets, many investors are rethinking which companies might benefit or struggle as this theme plays out. This article looks at three business...
Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying undervalued stocks can be a strategic approach for investors seeking opportunities where current prices may not fully reflect future growth potential.
Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests between management and shareholders.
Over the last 7 days, the U.S. market has dropped 2.6%, but it has risen by 14% over the past year, with earnings projected to grow annually by 17% in the coming years. In light of these conditions, investors may find value in penny stocks—an investment area that still holds relevance despite being an older term. By focusing on companies with solid financials and potential for growth, investors can uncover opportunities among smaller or less-established firms that might offer both stability...
BWX Technologies has delivered a very strong run over the last five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks currently point to the stock trading at a premium to those fundamentals.
BWX Technologies has returned 215.2% over five years, which sets a high bar for any further upside to be supported by fundamentals.
The company’s valuation can be supported by expectations for continued cash flow generation from its core defense and...
United Therapeutics (UTHR) stock is in focus after the company reported statistically significant phase 3 ADVANCE OUTCOMES results for its investigational PAH therapy ralinepag, with full data recently published in The Lancet.
See our latest analysis for United Therapeutics.
The latest ralinepag data and board appointment of Dr. Victor Dzau come as United Therapeutics trades at US$524.70, with the share price return up 5.63% year to date but the 90-day share price return down 8.16%. Over a...
Chubb stock has delivered a strong 126.4% total return over the past 5 years, yet the current checks send a mixed message, with the Excess Returns intrinsic value estimate suggesting the shares trade at a sizeable discount while the broader valuation framework does not flag the stock as an obvious bargain.
Over 5 years, Chubb has returned 126.4%, which puts recent share price strength at the center of any valuation discussion.
Future expectations for underwriting quality and capital...